Home / Brands / Dragon Pharma / Dragon Pharma Thymosin Alpha-1 10 mg Immune Peptide Vial
U.S Domestic Available Domestic
Dragon Pharma Thymosin Alpha-1 10 mg Immune Peptide Vial
Dragon Pharma

Dragon Pharma Thymosin Alpha-1 10 mg Immune Peptide Vial

Injection · 10 mg · vial

In stock · ships within 24h Out of stock
$140.00

Dragon Pharma Thymosin Alpha-1 is a synthetic 28 amino acid copy of the natural immune peptide, supplied as a 10 mg lyophilized research vial. It is studied as a biological response modifier in T-cell maturation and cytokine signalling. Clinical work uses a twice-weekly schedule.

GMP-manufactured and HPLC-verified, with a Certificate of Analysis on file per batch. Thymosin Alpha-1 10 mg for sale with U.S. domestic and international shipping.

Shipping Not available in this combination
1
Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted

Product overview

Dragon Pharma Thymosin Alpha-1 10 mg Research Vial

Dragon Pharma Thymosin Alpha-1 is a 10 mg lyophilized vial of the synthetic 28 amino acid peptide, also written as thymalfasin and sold elsewhere as Zadaxin. It is a biological response modifier rather than a hormone: the research focus is the T-cell side of immunity and the cytokine signals around it, which places the compound in the immune and longevity group of the line.

  • 10 mg lyophilized powder in a single vial - research use
  • Synthetic 28 amino acid immune peptide (thymalfasin)
  • GMP-manufactured and HPLC-verified - COA on file per batch
  • U.S. and international shipping

How Thymosin Alpha-1 Works

The peptide is a synthetic copy of a natural thymic signal studied as an immune modulator: animal work in thymus-free animals showed restored immune function, and the clinical literature covers chronic viral hepatitis, sepsis and immune support during cancer treatment. Pharmacokinetics are predictable: a peak 1 to 2 hours after a 900 mcg subcutaneous dose and a half-life of 2 to 3 hours, which is why clinical schedules inject twice weekly rather than daily. A 2023 review of hospitalised COVID-19 patients found no reduction in mortality or hospital stay, so the compound should not be read as a broad antiviral. The thymus-centred side of the shelf is covered by the Generic Peptides Thymosin Alpha-1 page.

Reconstitution & Storage

Dissolve the lyophilizate with bacteriostatic water against the vial wall, without shaking. A 10 mg vial in 5 ml gives 2 mg/ml, so 0.1 ml equals 200 mcg or 10 units on a U-100 syringe. Clinical reference doses are 0.8 to 6.4 mg twice weekly, and the standard hepatitis B schedule uses 1.6 mg twice weekly for about 12 weeks, six injections from this vial. Those figures are medical cross-checks, not a protocol for the research vial. Store the powder at 2-8 C away from light and use a solution within about 28 to 30 days. Bacteriostatic water is the standard diluent here.

Quality & Authenticity

Each batch is produced under GMP conditions and checked by third-party HPLC, with a Certificate of Analysis kept per batch. Store the vial upright, protect it from light and avoid repeated freeze-thaw cycles. The bioregulators on the same shelf, such as Livagen, follow the same GMP and COA convention.

For laboratory research only. Consult a healthcare professional before use.

Specifications

Trade NameThymosin Alpha-1
Generic NameThymalfasin (28 amino acid peptide)
ManufacturerDragon Pharma
Dosage10 mg per vial
Package1 lyophilized vial
Drug ClassResearch peptide, immune modulator
Half-Life2-3 hours after subcutaneous dosing
VerificationThird-party HPLC per batch, COA on file
ShippingU.S. domestic and international

Stacks

Immune Research Block on Its Own

Thymosin Alpha-1 1.6 mg twice weekly from the 10 mg vial, dissolved in bacteriostatic water, run as a 12 week laboratory observation window.

Outcome: a twice-weekly schedule that matches the clinical pharmacokinetic window of 2 to 3 hours.

PCT: not applicable - the peptide is not hormonal.

Restoration Shelf With Livagen and NAD+

Thymosin Alpha-1 twice weekly beside Livagen in a short block and NAD+ on the same weekly rhythm.

Outcome: three research items reported in one log, with no combined human trial behind the pairing.

PCT: not applicable - research compounds only.

Research compounds only. Consult a healthcare professional before any use. Amounts shown are clinical or vendor reference figures, not a dosing instruction.

FAQ

Before you ask

Questions, answered

It is a synthetic 28 amino acid copy of a natural thymic peptide, also called thymalfasin, and it is studied as a biological response modifier. Research directions include T-cell maturation and function, cytokine signalling, chronic viral hepatitis, sepsis and immune support during cancer treatment. Those are research directions, not promised outcomes, and there is no approved U.S. form of the peptide.

Add bacteriostatic water against the wall of the vial and swirl, do not shake. A 10 mg vial with 5 ml of diluent gives 2 mg/ml, where 0.1 ml is 200 mcg or 10 units on a U-100 syringe; the same ratio comes from 2 mg in 1 ml, so any vial size follows one simple rule. Keep the solution at 2-8 C and use it within about 28 to 30 days without freezing.

Clinical references sit at 0.8 to 6.4 mg subcutaneously twice weekly, and the standard hepatitis B schedule uses 1.6 mg twice weekly for about 12 weeks. The twice-weekly rhythm comes from the short half-life of 2 to 3 hours: the peptide clears quickly and the schedule keeps a background level rather than a single long action. From a 10 mg vial, 1.6 mg per injection works out to six injections, roughly three weeks of that schedule.

The fact sheet describes no liver toxicity signal and no fluid retention for the peptide, and injection site redness and irritation are the usual local complaint with this class. Rare allergic reactions are possible, which is why a small test amount is the sensible first step with any new peptide. The larger caveat is that a 2023 review in hospitalised COVID-19 patients found no benefit on mortality or length of stay, so expectations should stay modest.

The peptide is not named in the WADA prohibited list in the fact sheet, which means the sources checked show no ban rather than a documented permission. That distinction matters for anyone subject to testing: absence from the list is not a green light, and the status should be checked against the current list before any decision.

Store the lyophilized vial at 2-8 C, protected from light, and keep it dry; the vendor convention for long-term storage of the powder is a freezer. Do not refreeze a solution that has already been thawed. GenXXLGear ships Thymosin Alpha-1 10 mg with U.S. domestic and international shipping, and every batch carries a Certificate of Analysis from third-party HPLC testing.

No reviews yet

Be the first to share your experience with Dragon Pharma Thymosin Alpha-1 10 mg Immune Peptide Vial

Log in to write a review

Complete the cycle

Stack it with

View all
Dragon Pharma Adipotide 10 mg FTPP Research Peptide Vial U.S Domestic Available Domestic
Dragon Pharma

Dragon Pharma Adipotide 10 mg FTPP Research Peptide Vial

No reviews yet
$120.00